Beta-blocker efficacy according to heart rate and rhythm in patients with heart failure. Commentary on the cardiac insufficiency bisoprolol study II analysis

Cardiac Electrophysiology Review

Volumn 7, Issue 3, 2003, Pages 233-235

  Lechat, Philippe P ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Atrial fibrillation; Beta blocker; Cardiac rhythm; Heart rate; Hearth failure

Indexed keywords

AMIODARONE; BETA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BUCINDOLOL; CARVEDILOL; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METOPROLOL;

ADRENERGIC RECEPTOR BLOCKING; ADRENERGIC STIMULATION; ARTICLE; CLINICAL OBSERVATION; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART RATE; HEART RHYTHM; HUMAN; MORBIDITY; MORTALITY; OUTCOMES RESEARCH; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL;

ADRENERGIC BETA-ANTAGONISTS; BISOPROLOL; HEART CONDUCTION SYSTEM; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; METOPROLOL; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 1342329844     PISSN: 13852264     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CEPR.0000012389.01561.27     Document Type: Article

References (8)

1. CIBIS II Investigators and committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS II). Lancet 1999;353:9-13.
2. MERIT-HF study group. Effect of metoprolol CR/XL in chronic heart failure. Lancet 1999;353:2001-2007.
3. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Roecker EB, Schultz MK, DeMets DL for the Carvedilol Prospective Randomized Cumulative Survival Study group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651-1658.
4. The beta-blocker Evaluation of Survival Trial Investigators. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med 2001;344:1659-1667.
5. Lechat P, Hulot JS, Escolano S, Mallet A, Leizorovicz A, Werhlen-Grandjean M, Pochmalicki G, Dargie H, on behalf of the CIBIS II investigators. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II trial. Circulation 2001;103:1428-1433.
6. Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: Analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF). JACC 2002;40:491-498.
7. Poole-Wilson PA, Swedberg K, Cleland JGF, Di Lenarda A, Hanrath P, Komajda M, Lubsen J, Lutiger B, Metra M, Remme WJ, Torp-Pedersen C, Scherlag A, Skene A for the COMET investigators. Comparison of cardvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metopriolol European Trial (COMET): Randomized controlled trial. Lancet 2003;362:7-13.
8. Metra M, Giubbini R, Nodari S, Boldi E, Modena MG, Dei Cas L. Differential effects of beta-blockers in patients with heart failure. A prospective, randomized, double-blind comparison of the long term effects of metoprolol versus carvedilol. Circulation 2000;102:546-551.